Literature DB >> 17721818

Lipid peroxidation and antioxidant enzyme activities in vascular and Alzheimer dementias.

Angela Casado1, M Encarnación López-Fernández, M Concepción Casado, Rosario de La Torre.   

Abstract

It has been reported that oxidative stress may play a role in the pathogenesis of dementia of the Alzheimer type (AD) and the cerebral ischemia which causes vascular dementia (VD). We measured malondialdehyde (MDA) levels and superoxide dismutase (SOD), catalase (CAT), glutathione peroxidase (GPx) and glutathione reductase (GR) activities in blood samples from patients with AD and VD and in healthy non-demented controls (CTR) which similar ages to the patients, in order to evaluate the degree of oxidative stress in patients with AD and VD. A sample of 150 subjects consisting of 50 patients with AD; 50 patients with VD and 50 CTR, aged from 65 to 85 years on, was analyzed. Most of the changes observed were in SOD activity and MDA levels. Catalase activity were least affected. Significant differences were observed in SOD and GR activity between males and females in CRT and in patients with AD, but not in VD. We have found a decrease in antioxidant enzymes activities (SOD, CAT, GPx and GR) in patients with AD and VD and significant differences were observed between CRT and AD patients for ages from 65 to 74, 75 to 84 and from 85 years to 94 years in SOD activity and MDA levels (P < 0.001). MDA levels increase with age in VD, AD and CTR. No significant variation with respect to sex were detected, but significant variations in MDA levels were detected between CRT and patients with VD and AD (P < 0.001). We conclude that oxidative stress plays an important role in the brain damage for both AD and VD, being observed higher levels of oxidative stress for AD that for VD.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17721818     DOI: 10.1007/s11064-007-9453-3

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   3.996


  47 in total

1.  Determination of malonaldehyde in Alzheimer's disease: a comparative study of high-performance liquid chromatography and thiobarbituric acid test.

Authors:  P Bermejo; P Gómez-Serranillos; J Santos; E Pastor; P Gil; S Martín-Aragón
Journal:  Gerontology       Date:  1997       Impact factor: 5.140

Review 2.  Oxidative stress in brain aging, neurodegenerative and vascular diseases: an overview.

Authors:  E Mariani; M C Polidori; A Cherubini; P Mecocci
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2005-09-23       Impact factor: 3.205

3.  The generation of superoxide radical during the autoxidation of hemoglobin.

Authors:  H P Misra; I Fridovich
Journal:  J Biol Chem       Date:  1972-11-10       Impact factor: 5.157

4.  Human aging brain disorders: role of antioxidant enzymes.

Authors:  M R de la Torre; A Casado; M E López-Fernández; D Carrascosa; M C Casado; D Venarucci; V Venarucci
Journal:  Neurochem Res       Date:  1996-08       Impact factor: 3.996

5.  Free radicals and superoxide dismutase in blood of patients with Alzheimer's disease and vascular dementia.

Authors:  Y Ihara; T Hayabara; K Sasaki; Y Fujisawa; R Kawada; T Yamamoto; Y Nakashima; S Yoshimune; M Kawai; M Kibata; S Kuroda
Journal:  J Neurol Sci       Date:  1997-12-09       Impact factor: 3.181

6.  CAMDEX. A standardised instrument for the diagnosis of mental disorder in the elderly with special reference to the early detection of dementia.

Authors:  M Roth; E Tym; C Q Mountjoy; F A Huppert; H Hendrie; S Verma; R Goddard
Journal:  Br J Psychiatry       Date:  1986-12       Impact factor: 9.319

7.  Vascular dementia: diagnostic criteria for research studies. Report of the NINDS-AIREN International Workshop.

Authors:  G C Román; T K Tatemichi; T Erkinjuntti; J L Cummings; J C Masdeu; J H Garcia; L Amaducci; J M Orgogozo; A Brun; A Hofman
Journal:  Neurology       Date:  1993-02       Impact factor: 9.910

8.  Reduced risk of Alzheimer disease in users of antioxidant vitamin supplements: the Cache County Study.

Authors:  Peter P Zandi; James C Anthony; Ara S Khachaturian; Stephanie V Stone; Deborah Gustafson; JoAnn T Tschanz; Maria C Norton; Kathleen A Welsh-Bohmer; John C S Breitner
Journal:  Arch Neurol       Date:  2004-01

Review 9.  Oxidative stress signalling in Alzheimer's disease.

Authors:  Xiongwei Zhu; Arun K Raina; Hyoung-Gon Lee; Gemma Casadesus; Mark A Smith; George Perry
Journal:  Brain Res       Date:  2004-03-12       Impact factor: 3.252

10.  Oxidative stress in Alzheimer's and vascular dementias: masking of the antioxidant profiles by a concomitant Type II diabetes mellitus condition.

Authors:  Jorge A Serra; Enrique R Marschoff; Raúl O Domínguez; Eduardo M Guareschi; Arturo L Famulari; Miguel A Pagano; Eugenia S de Lustig
Journal:  J Neurol Sci       Date:  2004-03-15       Impact factor: 3.181

View more
  48 in total

1.  Dimethyl fumarate attenuates 2-VO-induced vascular dementia via activating the Nrf2 signaling pathway in rats.

Authors:  Navneet Dhaliwal; Jatinder Dhaliwal; Aagamjit Singh; Kanwaljit Chopra
Journal:  Inflammopharmacology       Date:  2021-01-18       Impact factor: 4.473

Review 2.  Involvements of the lipid peroxidation product, HNE, in the pathogenesis and progression of Alzheimer's disease.

Authors:  D Allan Butterfield; Miranda L Bader Lange; Rukhsana Sultana
Journal:  Biochim Biophys Acta       Date:  2010-02-20

Review 3.  Vascular cognitive impairment and Alzheimer's disease: role of cerebral hypoperfusion and oxidative stress.

Authors:  Hyun Ah Kim; Alyson A Miller; Grant R Drummond; Amanda G Thrift; Thiruma V Arumugam; Thanh G Phan; Velandai K Srikanth; Christopher G Sobey
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2012-08-08       Impact factor: 3.000

Review 4.  Biomarkers of lipid peroxidation in Alzheimer disease (AD): an update.

Authors:  Melissa A Bradley-Whitman; Mark A Lovell
Journal:  Arch Toxicol       Date:  2015-04-18       Impact factor: 5.153

Review 5.  Redox proteomics in selected neurodegenerative disorders: from its infancy to future applications.

Authors:  D Allan Butterfield; Marzia Perluigi; Tanea Reed; Tasneem Muharib; Christopher P Hughes; Renã A S Robinson; Rukhsana Sultana
Journal:  Antioxid Redox Signal       Date:  2012-01-18       Impact factor: 8.401

6.  Lysophosphatidic acid induces increased BACE1 expression and Aβ formation.

Authors:  Jing Shi; Yunzhou Dong; Mei-Zhen Cui; Xuemin Xu
Journal:  Biochim Biophys Acta       Date:  2012-10-02

7.  Oxidative damage increased in presenilin1/presenilin2 conditional double knockout mice.

Authors:  Dong-Li Zhang; Yi-Qun Chen; Xu Jiang; Ting-Ting Ji; Bing Mei
Journal:  Neurosci Bull       Date:  2009-06       Impact factor: 5.203

8.  NADPH oxidase 1, a novel molecular source of ROS in hippocampal neuronal death in vascular dementia.

Authors:  Dong-Hee Choi; Kyoung-Hee Lee; Ji-Hye Kim; Ju-Ha Seo; Hahn Young Kim; Chan Young Shin; Jung-Soo Han; Seol-Heui Han; Yoon-Seong Kim; Jongmin Lee
Journal:  Antioxid Redox Signal       Date:  2014-02-06       Impact factor: 8.401

9.  Antioxidants and cognitive training interact to affect oxidative stress and memory in APP/PSEN1 mice.

Authors:  F E Harrison; J Allard; R Bixler; C Usoh; L Li; J M May; M P McDonald
Journal:  Nutr Neurosci       Date:  2009-10       Impact factor: 4.994

Review 10.  Oxidative stress in diabetes and Alzheimer's disease.

Authors:  V Prakash Reddy; Xiongwei Zhu; George Perry; Mark A Smith
Journal:  J Alzheimers Dis       Date:  2009       Impact factor: 4.472

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.